新型冠状病毒Omicron I1566V突变位点MS2噬菌体病毒样颗粒的构建OACSTPCD
Construction of MS2 phage virus-like particles with Omicron I1566V mutation site of SARS-CoV-2
目的 构建新型冠状病毒Omicron I1566V突变位点 MS2噬菌体病毒样颗粒.方法 选取并合成带有6×His标签的MS2噬菌体的衣壳蛋白(CP)、成熟蛋白(A蛋白)及Omicron I1566V突变基因序列,插入pACYCDuet-1质粒构建重组载体,通过原核系统诱导表达目的蛋白,纯化重组蛋白后利用透射电镜对蛋白质进行物理表征,最后通过反转录聚合酶链反应(RT-PCR)检测病毒样颗粒的热稳定性及耐核酸酶水解能力.结果 成功构建包含有6×His标签的CP、A蛋白和Omicron I1566V突变基因序列的重组载体,经限制性内切酶BamH Ⅰ和Kpn Ⅰ酶切鉴定和测序验证,结果均与预期相符.经诱导并纯化后,通过电镜观察到了大小均匀、直径为23~28 nm的病毒样颗粒,该病毒样颗粒经核酸酶消化后可在37℃条件下稳定储存20 d以上.结论 该研究成功利用MS2噬菌体的CP和A蛋白构建了Omicron I1566V突变位点病毒样颗粒,为该突变位点的RT-PCR检测体系提供了可靠的质量保障.
Objective To construct MS2 phage virus-like particles with Omicron I1566V mutation site of SARS-CoV-2.Methods The capsid protein(CP),mature protein(A protein)and Omicron I1566V mutant gene sequences of MS2 phage with 6×His tag were selected and synthesized,and inserted into the pACYCDu-et-1 plasmid to construct the recombinant vector.The recombinant protein was purified and characterized by transmission electron microscopy.Finally,the thermal stability and nuclease resistance of the virus-like parti-cles were detected by reverse transcription polymerase chain reaction(RT-PCR).Results The recombinant vector containing CP and A protein with 6×His tag and Omicron I1566V mutant gene sequence was success-fully constructed.The results were confirmed by restriction enzyme BamH I and Kpn I digestion and sequen-cing.After induction and purification,the virus-like particles with a diameter of 23-28 nm were observed by electron microscopy.The virus-like particles were digested by nuclease and stored stably at 37℃for more than 20 days.Conclusion In this study,the Omicron I1566V mutation site virus-like particles were success-fully constructed using the CP and A protein of bacteriophage MS2,which provided reliable quality assurance for the RT-PCR detection system of Omicron I1566V mutation site.
杨静远;李永鑫;史茜;刘春燕;梁梦洁;张新
石河子大学医学院,新疆石河子 832000||新疆生产建设兵团医院/石河子大学医学院第二附属医院检验科,新疆乌鲁木齐 830002新疆生产建设兵团医院/石河子大学医学院第二附属医院检验科,新疆乌鲁木齐 830002
临床医学
新型冠状病毒变异株Omicron I1566V突变位点反转录聚合酶链反应MS2噬菌体病毒样颗粒
SARS-CoV-2 variantsOmicron I1566V mutationreverse transcriptase polymerase chain reactionbacteriophage MS2virus-like particles
《检验医学与临床》 2024 (008)
1030-1034 / 5
国家临床重点专科建设项目[兵财社(2023)16号];兵团临床医学研究中心建设项目[兵科发(2023)12号];兵团重点领域科技攻关计划项目(2022AB030);新疆生产建设兵团医院院级科技计划项目(2022014).
评论